Other News To Note
Monday, July 30, 2012
Sucampo Pharmaceuticals Inc., of Bethesda, Md., and Takeda Pharmaceutical Co. Ltd., of Osaka, Japan, said they filed a supplemental new drug application seeking approval to expand the use of Amitiza (lubiprostone) for treating opioid-induced constipation in patients with chronic, noncancer pain.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.